EyePoint Pharmaceuticals, Inc. (EYPT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for EyePoint Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.77x | -3.20x | -12.38x | -1.28x | -6.03x | -1.86x |
| P/B Ratio | 4.37x | 1.25x | 3.29x | 1.36x | 1.91x | 4.56x |
| P/S Ratio | 42.66x | 9.69x | 19.04x | 3.15x | 9.53x | 2.45x |
| Profitability | ||||||
| Gross Margin | 93.4% | 91.4% | 89.9% | 79.9% | 77.9% | 83.1% |
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | -108.3% |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | -131.8% |
| EBITDA Margin | -776.0% | -298.6% | -149.9% | -233.4% | -135.8% | -103.1% |
| Liquidity | ||||||
| Current Ratio | 8.88x | 7.81x | 5.45x | 5.00x | 10.05x | 4.24x |
| Quick Ratio | 8.83x | 7.77x | 5.39x | 4.92x | 9.90x | 3.88x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.06x | 0.02x | 0.48x | 0.21x | 2.21x |
YoY = year-over-year change. Source: FMP..